Third quarter report Q3-2021 - focusing on next trial (0205)
Cessatech A/S (“Cessatech” or the “Company”) today releases its results for the period 1 July – 30 September 2021. The third quarter report is available as an attached document to this press release and on www.cessatech.com under Investor, ‘Filings & Reports’. The company is on track with planned activities, has initiated recruitment of trial 0206 - a trial to investigate the pharmacokinetics in children aged 1-17 undergoing elective surgical procedures, and getting ready for trial 0205Third quarter 2021 (1 July – 30 September): · Net revenue was KDKK 0 · Operating result was KDKK -